An Act to provide rapid whole genome sequencing

HD 2659 mandates Medicaid coverage for rapid whole genome sequencing for Massachusetts children and young adults (under 21) hospitalized in intensive care with complex or acute illnesses of unknown cause. It requires coverage when specific clinical criteria are met, such as multiple congenital anomalies, abnormal metabolic tests, refractory seizures, or genetic-suggestive cardiac findings. The bill specifies results must be delivered within 5 days for preliminary findings and 14 days for final results. Genetic data generated is protected under HIPAA as health information, and the Executive Office of Health and Human Services must implement the policy, including seeking federal approval if needed.